

Oliver
Oliver is nine years old. He enjoys drawing, playing with Lego and watching films. He loves school, playing rugby and football. After completing frontline treatment for high-risk neuroblastoma in 2021 and the bivalent vaccine clinical trial in America, Oliver sadly relapsed just before Christmas in 2024.
Oliver’s story
Oliver was diagnosed with high-risk neuroblastoma on 17 January 2020 – a lump had been found on his kidney and the cancer had spread to his bone marrow, skull and eye sockets. Chemotherapy started for Oliver the very next day. He had nine rounds altogether, quickly recovering each time, which meant he could enjoy the attention from the nurses and playing with toys in the playroom. He then had surgery to remove the tumour, high-dose chemotherapy, stem cell transplant (which made him very poorly) and radiotherapy.
After frontline treatment finished, thanks to Oliver’s incredible community of support, over £200,000 was raised, which meant his family were able to fulfil their wishes to enrol him on the bivalent vaccine clinical trial at Memorial Sloan Kettering Cancer Center in New York, which he completed in April 2022.
Oliver’s mum and dad say that he gave them the strength and bravery to get through everything and they are so proud of him.
Relapse and further treatment
In December 2024, just days before Christmas and Oliver’s ninth birthday he began complaining of pain in his ribs, which his parents initially put down to his being a goalkeeper and falling on the floor often. Their GP sent him for an x-ray which devastatingly showed two new tumours, throwing the families world upside down.
Just days after Christmas Oliver started treatment once again, a combination of chemotherapies given over a 21-day cycle.
Solving Kids' Cancer UK's children's fundraising campaigns
Oliver's fundraising campaign for access to treatment raised £214,521 before it was closed. Funds raised through a child's fundraising campaign are spent on their treatment and pastoral needs. Any remaining funds, and all funds raised after five years post the end of the child's treatment, are used to support other children and families through Solving Kids' Cancer UK's activities.